Kenacort^® Retard (Triamcinolone acetonide), from Laboratoires Squibb (Paris), 1974

Today, triamcinolone acetonide remains a commonly used corticosteroid hormone for the treatment of hypertrophic scars, atopic dermatitis and other arthritic or dermatologic conditions. In oncology, the drug can be used for the management of malignant ascites or pleural effusions.